As market pressures demand increased innovation and shorter time-to-market product lifecycles, pharmaceutical companies need to re-think evaluating alternative business models, focusing on technologies – such as business intelligence (BI) tools. BI helps measure Key Performance Indicators which should be monitored as a part of any business strategy across the industries.

Posted on May 10th, 2010 by Dhiren Gala
Filed under: Business Intelligence | No Comments »